{"meta":{"query_hash":"e36033996a1e","filters":{"venue":"Revisiones en Cáncer"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/e36033996a1e","api":"https://metacan.xera.ac/api/v1/cohort?venue=Revisiones+en+C%C3%A1ncer"},"results":[{"id":"W4384076785","doi":"10.20960/revcancer.00025","title":"Beyond the first line of HER2+ metastatic breast cancer","year":2023,"lang":"es","type":"article","venue":"Revisiones en Cáncer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seagen (Canada)","funders":"","keywords":"Metastatic breast cancer; Breast cancer; Oncology; Medicine; Internal medicine; Cancer","score_opus":0.052102977007611,"score_gpt":0.41777546711219415,"score_spread":0.36567249010458314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384076785","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019086031,0.6023055,0.008273096,0.20352323,0.022819275,0.000074260315,0.0005096811,0.00037628654,0.14303267],"genre_scores_gemma":[0.2748795,0.502694,0.0081599485,0.09328253,0.03609868,0.00012676216,0.00064131076,0.00020668178,0.083910644],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99914074,0.00030376794,0.00006779853,0.00012746095,0.0002118164,0.00014843671],"domain_scores_gemma":[0.9980902,0.0006674394,0.00024337103,0.0001811772,0.0004970814,0.00032071865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020579267,0.00039718582,0.0006309881,0.0009025219,0.0004488683,0.0019459605,0.00068554917,0.001488449,0.008320632],"category_scores_gemma":[0.003656294,0.00014783916,0.00067840447,0.0004225097,0.0012406205,0.0019640557,0.0014752061,0.003415977,0.0020595146],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004539335,0.00019070304,0.0026211082,0.0024322604,0.00009802257,0.0017216406,0.00045703194,0.00083562644,0.0057035964,0.116712935,0.17883822,0.6899349],"study_design_scores_gemma":[0.00005579075,0.00031420766,0.0029593802,0.0016793491,0.000060875926,0.0038674625,0.00018273364,0.00038496775,0.0017034891,0.02743698,0.9613202,0.000034474273],"about_ca_topic_score_codex":0.0019335569,"about_ca_topic_score_gemma":0.004788059,"teacher_disagreement_score":0.008320632,"about_ca_system_score_codex":0.002442908,"about_ca_system_score_gemma":0.0024760657,"threshold_uncertainty_score":0.02783525},"labels":[],"label_agreement":null}]}